Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Esco Technologies | ESE | Oct 31, 2024 | 125.54 | -3.08 |
ESGL | ESGL | Oct 31, 2024 | 1.72 | -1.30 |
ESH Acquisition | ESHA | Oct 31, 2024 | 10.66 | +0.09 |
Eshallgo | EHGO | Oct 31, 2024 | 3.31 | +5.94 |
Esperion Therapeutics | ESPR | Oct 31, 2024 | 2.04 | -4.23 |
Espey Mfg & Electronics | ESP | Oct 31, 2024 | 31.30 | +3.13 |
Esquire Financial | ESQ | Oct 31, 2024 | 66.58 | -0.82 |
ESS Tech | GWH | Oct 31, 2024 | 7.49 | -3.10 |
ESSA Bancorp | ESSA | Oct 31, 2024 | 18.82 | -2.34 |
ESSA Pharma | EPIX | Oct 31, 2024 | 5.20 | -1.52 |
Essent Group | ESNT | Oct 31, 2024 | 60.01 | -1.62 |
Essential Properties Realty Trust | EPRT | Oct 31, 2024 | 31.69 | -1.77 |
Essential Utilities | WTRG | Oct 31, 2024 | 38.60 | -0.36 |
Essex Property Trust | ESS | Oct 31, 2024 | 283.86 | -3.46 |
Establishment Labs | ESTA | Oct 31, 2024 | 43.09 | -4.18 |
Estee Lauder Companies | EL | Oct 31, 2024 | 68.94 | -20.90 |
Estrella Immunopharma | ESLA | Oct 31, 2024 | 0.80 | -1.80 |
Eterna Therapeutics | ERNA | Oct 31, 2024 | 1.09 | -0.91 |
ETFMG Alternative Harvest ETF | MJ | Oct 31, 2024 | 3.13 | -2.19 |
Ethan Allen Interiors | ETD | Oct 31, 2024 | 27.67 | -5.88 |
Eton Pharmaceuticals | ETON | Oct 31, 2024 | 8.47 | -2.64 |
Etsy | ETSY | Oct 31, 2024 | 51.44 | +7.19 |
Euda Health | EUDA | Oct 31, 2024 | 4.25 | -5.97 |
Eupraxia Pharmaceuticals | EPRX | Oct 31, 2024 | 2.50 | 0.00 |
Eureka Acquisition | EURKU | Oct 31, 2024 | 10.40 | 0.00 |
Eureka Acquisition | EURK | Oct 31, 2024 | 10.08 | 0.00 |
Euro Tech Holdings | CLWT | Oct 31, 2024 | 1.54 | -0.65 |
Euro Trust | FXE | Oct 31, 2024 | 100.51 | +0.16 |
EuroDry | EDRY | Oct 31, 2024 | 17.63 | -0.69 |
Euronav | EURN | Oct 31, 2024 | 16.31 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.